These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 22403845
1. Pharmaceuticals and medical devices: FDA oversight. Health Policy Tracking Service, a service of Thomson Reuters Accelus, Berry MD. Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-86. PubMed ID: 22403845 [No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: FDA oversight. Issue brief. Berry MD. Issue Brief Health Policy Track Serv; 2012 Dec 31; ():1-79. PubMed ID: 23297449 [No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA. Issue Brief Health Policy Track Serv; 2010 Jan 04; ():1-31. PubMed ID: 20217914 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: FDA oversight. Berry MD. Issue Brief Health Policy Track Serv; 2013 Dec 30; ():1-123. PubMed ID: 24482893 [No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight. Chaps NA. Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: FDA oversight. Issue brief. Thomson Reuters/West. Issue Brief Health Policy Track Serv; 2011 Jan 03; ():1-39. PubMed ID: 21374841 [No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA. Issue Brief Health Policy Track Serv; 2008 Jan 07; ():1-18. PubMed ID: 18345557 [No Abstract] [Full Text] [Related]
9. Drug safety reform at the FDA--pendulum swing or systematic improvement? McClellan M. N Engl J Med; 2007 Apr 26; 356(17):1700-2. PubMed ID: 17435081 [No Abstract] [Full Text] [Related]
10. Pros and cons of off-label promotion investigations and prosecutions. Loucks MK. Food Drug Law J; 2006 Apr 26; 61(3):577-83. PubMed ID: 16989041 [No Abstract] [Full Text] [Related]
15. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM, Curry JA. Tort Trial Insur Pract Law J; 2007 Dec 31; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: cost savings. Health Policy Tracking Service, a service of Thomson Reuters Accelus, Steiner DJ. Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
17. Drug safety special: chasing shadows. Frantz S. Nature; 2005 Mar 31; 434(7033):557-8. PubMed ID: 15800592 [No Abstract] [Full Text] [Related]
18. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health. Gostin LO. JAMA; 2009 May 20; 301(19):2036-7. PubMed ID: 19454642 [No Abstract] [Full Text] [Related]
19. New drug law to speed scientific review. Nature; 1992 Oct 15; 359(6396):563. PubMed ID: 1406977 [Abstract] [Full Text] [Related]
20. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration? Zelenay JL. Food Drug Law J; 2005 Oct 15; 60(2):261-338. PubMed ID: 16094773 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]